GO
Loading...

Biogen Idec Inc

More

  • Early Glance: Biotechnology companies Thursday, 11 Dec 2014 | 11:28 AM ET

    Amgen Inc. rose $2.53 or 1.5 percent, to $167.92. Biogen Idec rose $2.90 or. 8 percent, to $346.49. Celgene Corp. rose $1.91 or 1.7 percent, to $117.55.

  • Final Glance: Biotechnology companies Wednesday, 10 Dec 2014 | 6:09 PM ET

    Amgen Inc. fell $4.00 or 2.4 percent, to $165.39. Biogen Idec fell $4.02 or 1.2 percent, to $343.59. Celgene Corp. fell $3.04 or 2.6 percent, to $115.64.

  • Midday Glance: Biotechnology companies Wednesday, 10 Dec 2014 | 1:18 PM ET

    Amgen Inc. fell $1.19 or. 7 percent, to $168.20. Biogen Idec fell $1.82 or. 5 percent, to $345.79. Celgene Corp. fell$. 97 or. 8 percent, to $117.71.

  • Early Glance: Biotechnology companies Wednesday, 10 Dec 2014 | 10:41 AM ET

    Amgen Inc. rose$. 07 or percent, to $169.46. Biogen Idec fell$. 17 or percent, to $347.44. Celgene Corp. fell$. 39 or. 3 percent, to $118.29.

  • Final Glance: Biotechnology companies Tuesday, 9 Dec 2014 | 6:10 PM ET

    Amgen Inc. fell $2.25 or 1.3 percent, to $169.39. Biogen Idec rose $3.56 or 1.0 percent, to $347.61. Celgene Corp. rose$. 49 or. 4 percent, to $118.68.

  • Midday Glance: Biotechnology companies Tuesday, 9 Dec 2014 | 1:21 PM ET

    Amgen Inc. fell $2.16 or 1.3 percent, to $169.48. Biogen Idec fell$. 23 or. 1 percent, to $343.82. Celgene Corp. rose$. 35 or. 3 percent, to $118.54.

  • Early Glance: Biotechnology companies Tuesday, 9 Dec 2014 | 10:21 AM ET

    Amgen Inc. fell $2.53 or 1.5 percent, to $169.11. Biogen Idec fell $2.51 or. 7 percent, to $341.54. Celgene Corp. fell $1.02 or. 9 percent, to $117.17.

  • Final Glance: Biotechnology companies Monday, 8 Dec 2014 | 6:02 PM ET

    Amgen Inc. rose $2.40 or 1.4 percent, to $171.64. Biogen Idec rose $3.18 or. 9 percent, to $344.05. Celgene Corp. rose $4.06 or 3.6 percent, to $118.19.

  • Midday Glance: Biotechnology companies Monday, 8 Dec 2014 | 1:20 PM ET

    Amgen Inc. rose $3.10 or 1.8 percent, to $172.34. Biogen Idec rose $3.09 or. 9 percent, to $343.96. Celgene Corp. rose $4.42 or 3.9 percent, to $118.55.

  • Early Glance: Biotechnology companies Monday, 8 Dec 2014 | 10:22 AM ET

    Amgen Inc. rose $2.22 or 1.3 percent, to $171.46. Biogen Idec rose $4.43 or 1.3 percent, to $345.30. Celgene Corp. rose $3.86 or 3.4 percent, to $117.99.

  • Mario Draghi is all over the place on ECB action Thursday, 4 Dec 2014 | 10:28 AM ET

    European stocks weakened and the euro shot higher as the ECB chief implied any initiative to purchase sovereign debt isn't imminent.

  • Cramer’s big discovery under the market's hood Wednesday, 3 Dec 2014 | 6:16 PM ET

    Jim Cramer takes a close look under the market's hood and makes a big discovery that could impact your portfolio.

  • Wednesday's midday movers: Apple, Kraft & more Wednesday, 3 Dec 2014 | 12:26 PM ET
    Traders on the floor of the New York Stock Exchange, December 1, 2014.

    Take a look at some of Wednesday's midday movers:

  • Cramer Remix: The best stocks to own now Tuesday, 2 Dec 2014 | 7:07 PM ET

    It’s this stock, and its partner in crime, that "Mad Money" host Jim Cramer believes are heading higher.

  • Cramer's heated love affair with biotech Tuesday, 2 Dec 2014 | 6:33 PM ET
    File photo: Michael LeClair, left, and Kevin Fleurimond, in the manufacturing room of Biogen Idec.

    As the global economy faces headwinds each day, Jim Cramer knows this group can withstand stormy weather more often than the rest.

  • Otsuka to buy Avanir; Cypress Semi to buy Spansion. The only group to fall was telecoms, down 1.8 percent with AT&T down 2.2 percent at $34.29 and Verizon down 1.8 percent at $49.11. Sprint announced it will cut in half the monthly price of service for Verizon and AT&T customers who switch to Sprint.

  • *Otsuka to buy Avanir; Cypress Semi to buy Spansion. The only group to fall was telecoms, down 1.6 percent with AT&T down 2.1 percent and Verizon down 1.5 percent. Sprint announced it will cut in half the monthly price of service for Verizon and AT&T customers who switch to Sprint.

  • *U.S. stocks climb with energy shares; MSCI global stock index up. NEW YORK, Dec 2- Oil prices resumed their decline on Tuesday after rallying the previous session, while world stock markets edged higher as investors snapped up beaten-down energy shares. MSCI's global share index was up 0.2 percent.

  • Midday movers: Biogen Idec, Priceline, BP & more Tuesday, 2 Dec 2014 | 12:43 PM ET

    Some of Tuesday's midday movers

  • Dec 2- Biogen Idec Inc's research chief on Tuesday said the company is planning a late-stage trial of its experimental treatment for Alzheimer's disease after the drug cut brain plaque levels and significantly improved cognition in a small early-stage study. Brain swelling has been a recurrent issue with experimental anti-amyloid Alzheimer's drugs,...